Skip to content

Physical Activity on Prescription in Overweight Older Adults

Physical Activity in Prevention and Treatment of Overweight, Central Obesity and the Metabolic Syndrome - a Randomised Controlled Study in Overweight 65 Year Old Women and Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02320760
Enrollment
102
Registered
2014-12-19
Start date
2005-01-31
Completion date
2009-05-31
Last updated
2014-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Physical Activity Level, Central Obesity, Metabolic Syndrome

Brief summary

This randomized controlled study evaluates the effect of individualized physical activity on prescription (PAP) in older overweight adults. The primary hypothesis is that an individualized prescription of physical activity increases physical activity level in overweight older adults after 6 months. Secondary hypothesis are that the increased physical activity level will improve cardio metabolic risk factors and quality of life. 200 women and men, aged 65 with low physical activity level, overweight, and abdominal obesity, will be randomized to an intervention group or a control group. The control group receives general information about physical activity and registration of physical activity level for one week. The intervention group receives in addition an individualized physical activity on prescription with patient-centered counseling. After six months both groups go through the same health check-up as at baseline and follow-ups take place after 12 and 24 months.

Interventions

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
65 Years to 69 Years

Inclusion criteria

* BMI between 25 and 40 * waist circumference over 88 cm for women and 102 cm for men * basically healthy * mostly sedentary in their leisure time

Exclusion criteria

* current heart disease * tablet or insulin treated diabetes type 2 * cancer * other chronic serious illness

Design outcomes

Primary

MeasureTime frame
physical activity level6 months

Secondary

MeasureTime frame
cardiometabolic risk factors6 months

Other

MeasureTime frame
Quality of life6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026